Nanomedicines Market, By Application (Cardiovascular, Anti-inflammatories, Anti-infectives, Neurology, Oncology, Others ), and By Region - Size, Share, Outlook, and Opportunity Analysis, 2022

Description

Nanomedicine products have applications in drug delivery, in vivo imaging, in vitro diagnostics, regenerative medicine, dental, medical devices, and dermal applications. Major drivers for the global nanomedicine market constitutes of increasing government support as well as continuous increase in the occurrence of chronic diseases including diabetes, obesity, cancer, orthopedic diseases, and kidney disorder. Furthermore, major players in the global nanomedicine market are focused on R&D of new products to expand their product portfolio.

Key features of the study:

This report provides in-depth analysis of the Global Nanomedicines market and provides market size (US$ billion) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
It profiles key players in the Global Nanomedicines market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include, Abbott Laboratories, CombiMatrix Corporation, Clene Nanomedicine, Inc., Cellics Therapeutics, Inc., Nanobiotix S.A, Celgene Corporation, GE Healthcare, NanoViricides, Inc., Johnson & Johnson, Mallinckrodt plc., Sirnaomics Inc., Precision NanoSystems Inc., Merck & Company Inc., Nanosphere, Inc., Pfizer Inc., and Sigma-Tau Pharmaceuticals Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The Global Nanomedicines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Nanomedicines market

Detailed Segmentation:

Global Nanomedicines Market, By Application:
- Cardiovascular
- Anti-inflammatories
- Anti-infectives
- Neurology
- Oncology
- Others (dental, orthopedic, urology, ophthalmic)
Global Nanomedicines Market, By Region:
- North America
  - By Application
  - Cardiovascular
  - Anti-inflammatories
  - Anti-infectives
  - Neurology
  - Oncology
  - Others (dental, orthopedic, urology, ophthalmic)
  - By Country
  - U.S.
  - Canada
- Latin America
  - By Application
  - Cardiovascular
  - Anti-inflammatories
  - Anti-infectives
  - Neurology
  - Oncology
  - Others (dental, orthopedic, urology, ophthalmic)
  - By Country
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
- Europe
  - By Application
  - Cardiovascular
  - Anti-inflammatories
  - Anti-infectives
  - Neurology
  - Oncology
  - Others (dental, orthopedic, urology, ophthalmic)
  - By Country
  - U.K.
  - Germany
  - France
  - Spain
  - Italy
  - Russia
  - Rest of Europe
- Asia Pacific
  - By Application
  - Cardiovascular
  - Anti-inflammatories
  - Anti-infectives
  - Neurology
  - Oncology
  - Others (dental, orthopedic, urology, ophthalmic)
  - By Country
  - China
  - Japan
  - India
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
- Middle East
  - By Application
  - Cardiovascular
  - Anti-inflammatories
  - Anti-infectives
  - Neurology
  - Oncology
  - Others (dental, orthopedic, urology, ophthalmic)
  - By Country
  - GCC Countries
  - Israel
  - Rest of Middle East
- Africa
  - By Application
  - Cardiovascular
  - Anti-inflammatories
  - Anti-infectives
  - Neurology
  - Oncology
  - Others (dental, orthopedic, urology, ophthalmic)
  - By Country
  - North Africa
  - Central Africa
  - South Africa
Company Profiles
- Abbott Laboratories *
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- CombiMatrix Corporation
- Clene Nanomedicine, Inc.
- Cellics Therapeutics Inc.
- Nanobiotix S.A
- Celgene Corporation
- GE Healthcare
- NanoViricides, Inc.
- Johnson & Johnson
- Mallinckrodt plc.
- Sirnaomics Inc.
- Precision NanoSystems Inc.
- Merck & Company Inc.
- Nanosphere, Inc.
- Pfizer Inc.
- Sigma-Tau Pharmaceuticals Inc.
"*" marked represents similar segmentation in other categories in the respective section.

Product Code: CMI393

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Application
- Market Snippet, By Country
- Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Key Highlights
Product launch
PEST Analysis
Technological Advancements
Regulatory Scenario
Mergers and Acquisitions

4. Global Nanomedicines Market, By Application, 2017 - 2028, (US$ Bn)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Cardiovascular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)
Anti-inflammatories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)
Anti-infective
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)
Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)
Others (dental, orthopedic, urology, opthalmic)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)

5. Global Nanomedicines Market, By Region, 2017 - 2028, (US$ Bn)

Introduction
- Market Share Analysis, By Region, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, For Regions, 2017 - 2028
North America
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Bn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Bn)
- U.S.
- Canada
Latin America
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Bn)Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Bn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Bn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Bn)
- Germany
- U.K.
- France
- Spain
- Italy
- Russia
- Rest of Europe
Asia Pacific
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Bn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Bn)
- China
- Japan
- India
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Bn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Bn)
- GCC Countries
- Israel
- Rest of Middle East
Africa
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Bn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Bn)
- North Africa
- Central Africa
- South Africa

6. Competitive Landscape

Company Profiles
- Abbott Laboratories
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- CombiMatrix Corporation
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Clene Nanomedicine, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Cellics Therapeutics Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Nanobiotix S.A
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Celgene Corporation
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- GE Healthcare
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- NanoViricides, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Johnson & Johnson
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Mallinckrodt plc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Sirnaomics Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Precision NanoSystems Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Merck & Company Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Nanosphere, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Pfizer Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Sigma-Tau Pharmaceuticals Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies

7. Section

References
Research Methodology
About us and Sales Contact

Nanomedicines Market, By Application (Cardiovascular, Anti-inflammatories, Anti-infectives, Neurology, Oncology, Others ), and By Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028